Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-070383

EVP, Chief Medical Officer sold 943 shares at $31.86 ($30,047)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burnett Patrick EVP, Chief Medical Officer 2026-11-02 Sale −943 $31.86 $30,047 116,649 D: show line 1 in the form
Open-market sales · 943 sh · avg $31.86 · $30,047
Loading xslF345X06/wk-form4_1793835520.xml…